Opportunity
DIBBS #SPE2DP-26-T-4627
DLA Procurement of Gabapentin Capsules, 100 mg, 100-count Bottles
Posted
August 13, 2026
Respond By
August 18, 2026
Identifier
SPE2DP-26-T-4627
NAICS
424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA seeking Gabapentin Capsules for military medical use. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - Office: Buyer Code DJM0448 - OEMs (Approved Manufacturers): - Marlex Pharmaceuticals Inc (NDC10135-0644-01) - Cipla USA Inc (NDC69097-0813-07) - Sciegen Pharmaceuticals Inc (NDC50228-0179-01) - Products Requested: - Gabapentin Capsules, 100 mg, 100-count bottles (NSN 6505-01-387-1892) - Total quantity: 7 bottles (5 for USS Makin Island LHD 8, 2 for 0087 CS BN CO A Composite at Fort Stewart, GA) - Notable Requirements: - Only the listed OEMs are approved sources - Packaging and marking must comply with medical standards and hazardous material regulations - Compliance with Buy American and domestic sourcing laws is required - Fast delivery required: within 5 days of order - Not a small business set-aside
Description
GABAPENTIN CAPSULES (QTY: 5, NSN: 6505-01-387-1892, Purchase Request: 7016153280) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC
GABAPENTIN CAPSULES (QTY: 2, NSN: 6505-01-387-1892, Purchase Request: 7016615962) Approved Sources: - CAGE: 1TAP7, Part No: NDC10135-0644-01, Company: MARLEX PHARMACEUTICALS INC - CAGE: 7WV84, Part No: NDC69097-0813-07, Company: CIPLA USA INC - CAGE: 8NLP1, Part No: NDC50228-0179-01, Company: SCIEGEN PHARMACEUTICALS INC